These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38487574)

  • 1. Cannabidiol usage, efficacy, and side effects: analyzing the impact of health conditions, medications, and cannabis use in a cross-sectional online pilot study.
    Binkowska AA; Jakubowska N; Redeł A; Laskowska S; Szlufik S; Brzezicka A
    Front Psychiatry; 2024; 15():1356009. PubMed ID: 38487574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usage and health perception of cannabidiol-containing products among the population in Germany: a descriptive study conducted in 2020 and 2021.
    Geppert J; Lietzow J; Hessel-Pras S; Kirsch F; Schäfer B; Sachse B
    BMC Public Health; 2023 Nov; 23(1):2318. PubMed ID: 37996800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems.
    Moltke J; Hindocha C
    J Cannabis Res; 2021 Feb; 3(1):5. PubMed ID: 33602344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cross-Sectional Study of Cannabidiol Users.
    Corroon J; Phillips JA
    Cannabis Cannabinoid Res; 2018; 3(1):152-161. PubMed ID: 30014038
    [No Abstract]   [Full Text] [Related]  

  • 5. Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey.
    Boehnke KF; Gagnier JJ; Matallana L; Williams DA
    J Pain; 2021 Nov; 22(11):1418-1428. PubMed ID: 33992787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
    Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
    PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.
    Fedorova EV; Wong CF; Ataiants J; Iverson E; Conn BM; Lankenau SE
    Drug Alcohol Depend; 2021 Apr; 221():108648. PubMed ID: 33676073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Factors Associated With Vaping Cannabidiol Among US Adolescents.
    Dai HD; Subramanian R; Mahroke A; Wang M
    JAMA Netw Open; 2023 Aug; 6(8):e2329167. PubMed ID: 37585202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol (CBD): Perspectives from Pinterest.
    Merten JW; Gordon BT; King JL; Pappas C
    Subst Use Misuse; 2020; 55(13):2213-2220. PubMed ID: 32715862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers.
    Zenone MA; Snyder J; Crooks V
    BMC Public Health; 2021 Jul; 21(1):1285. PubMed ID: 34210299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and Perceptions of Cannabidiol Products in Canada and in the United States.
    Goodman S; Wadsworth E; Schauer G; Hammond D
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):355-364. PubMed ID: 33998872
    [No Abstract]   [Full Text] [Related]  

  • 12. Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops.
    Leas EC; Moy N; McMenamin SB; Shi Y; Benmarhnia T; Stone MD; Trinidad DR; White M
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults.
    Wheeler M; Merten JW; Gordon BT; Hamadi H
    Subst Use Misuse; 2020; 55(7):1138-1145. PubMed ID: 32093530
    [No Abstract]   [Full Text] [Related]  

  • 14. Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey.
    Boehnke KF; Gagnier JJ; Matallana L; Williams DA
    J Pain; 2021 May; 22(5):556-566. PubMed ID: 33400996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A "Good" Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use.
    Fortin D; Di Beo V; Massin S; Bisiou Y; Carrieri P; Barré T
    Front Psychiatry; 2022; 13():829944. PubMed ID: 35370865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products.
    Tran T; Kavuluru R
    Int J Drug Policy; 2020 Mar; 77():102688. PubMed ID: 32092666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap.
    Cleirec G; Desmier E; Lacatus C; Lesgourgues S; Braun A; Peloso C; Obadia C
    Front Psychiatry; 2022; 13():899221. PubMed ID: 35686188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.
    Bhardwaj AK; Mills L; Doyle M; Sahid A; Montebello M; Monds L; Arunogiri S; Haber P; Lorenzetti V; Lubman DI; Malouf P; Harrod ME; Dunlop A; Freeman T; Lintzeris N
    BMC Psychiatry; 2024 Mar; 24(1):175. PubMed ID: 38433233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional and longitudinal evaluation of cannabidiol (CBD) product use and health among people with epilepsy.
    Strickland JC; Jackson H; Schlienz NJ; Salpekar JA; Martin EL; Munson J; Bonn-Miller MO; Vandrey R
    Epilepsy Behav; 2021 Sep; 122():108205. PubMed ID: 34311183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.